On Friday, Genelux Corp (NASDAQ: GNLX) opened lower -5.67% from the last session, before settling in for the closing price of $3.53. Price fluctuations for GNLX have ranged from $1.95 to $5.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -14.03%. Company’s average yearly earnings per share was noted 8.63% at the time writing. With a float of $33.10 million, this company’s outstanding shares have now reached $37.33 million.
Genelux Corp (GNLX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Genelux Corp is 12.38%, while institutional ownership is 19.38%. The most recent insider transaction that took place on May 12 ’25, was worth 13,067. In this transaction General Counsel of this company sold 4,475 shares at a rate of $2.92, taking the stock ownership to the 47,621 shares. Before that another transaction happened on May 12 ’25, when Company’s President and CEO sold 10,764 for $2.92, making the entire transaction worth $31,431. This insider now owns 191,447 shares in total.
Genelux Corp (GNLX) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.19 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.19) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.57% during the next five years compared to -14.03% drop over the previous five years of trading.
Genelux Corp (NASDAQ: GNLX) Trading Performance Indicators
Check out the current performance indicators for Genelux Corp (GNLX). In the past quarter, the stock posted a quick ratio of 4.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.86, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.96 in one year’s time.
Technical Analysis of Genelux Corp (GNLX)
Looking closely at Genelux Corp (NASDAQ: GNLX), its last 5-days average volume was 0.11 million, which is a drop from its year-to-date volume of 0.18 million. As of the previous 9 days, the stock’s Stochastic %D was 29.64%.
During the past 100 days, Genelux Corp’s (GNLX) raw stochastic average was set at 64.48%, which indicates a significant increase from 28.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.24 in the past 14 days, which was lower than the 0.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.32, while its 200-day Moving Average is $3.12. However, in the short run, Genelux Corp’s stock first resistance to watch stands at $3.54. Second resistance stands at $3.76. The third major resistance level sits at $3.88. If the price goes on to break the first support level at $3.21, it is likely to go to the next support level at $3.09. Now, if the price goes above the second support level, the third support stands at $2.87.
Genelux Corp (NASDAQ: GNLX) Key Stats
There are currently 37,773K shares outstanding in the company with a market cap of 125.79 million. Presently, the company’s annual sales total 10 K according to its annual income of -29,870 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,460 K.
